# Emergency Chest Pain Center: A Novel Approach to Reduce Door to Balloon Time

**Authors:** Marwa A. Sabe, Frank J. Kaeberlein, Sharif A. Sabe, Allyson Kelly, Tracy Summerfield, Ahmed A. Sabe

PMC · DOI: 10.1016/j.jacadv.2025.101774 · JACC: Advances · 2025-05-13

## TL;DR

A new approach placing a catheterization lab in the emergency department reduced treatment time and mortality for heart attack patients.

## Contribution

Introducing an emergency department-based catheterization lab to reduce door-to-balloon time for STEMI patients.

## Key findings

- ED catheterization lab patients had significantly shorter door-to-balloon times (54 vs 83 minutes).
- ED catheterization lab patients had lower 30-day, 1-year, and 10-year mortality rates.
- ED catheterization lab implementation is a feasible strategy for improving STEMI outcomes.

## Abstract

Percutaneous coronary intervention is the preferred treatment for acute ST-segment elevation myocardial infarction (STEMI), and shorter door-to-balloon time (D2B) is associated with lower mortality. We implemented a catheterization laboratory within the emergency department (ED) as a novel strategy to reduce D2B.

The purpose of this paper was to compare D2B and mortality in STEMI patients presenting to ED vs standard catheterization labs at a community hospital.

We prospectively reviewed consecutive patients presenting with STEMI to our institution between 1998 and 2011 and treated with primary percutaneous coronary intervention. The primary endpoints were D2B and time to death. A multivariable linear regression model was used to assess the relationship between catheterization lab location and D2B. The relationship between D2B and mortality was examined using a Cox proportional hazards model.

We included 1,053 STEMI patients (553 in ED vs 500 in standard catheterization labs). Both groups had similar age, sex, race, diabetes, left main disease, and Killip class on presentation. Standard catheterization lab patients were more likely to have left ventricular ejection fraction <40% (11% vs 6.5%). D2B was shorter in ED vs standard cath lab patients (54 vs 83 minutes, P < 0.001). ED catheterization lab patients were more likely to have <30-minute D2B (17% vs <1%, P < 0.001). After covariate adjustment, ED catheterization lab patients had lower 30-day (adjusted hazard ratio [adj HR]: 0.54, 95% confidence interval [CI] 0.29-0.99), 1-year (adj HR: 0.58, 95% CI: 0.37-0.91), and 10-year mortality (adj HR: 0.39, 95% CI: 0.29-0.53) than standard catheterization lab patients.

Implementation of an ED catheterization lab is a feasible strategy which may reduce D2B and STEMI mortality.

## Linked entities

- **Diseases:** acute ST-segment elevation myocardial infarction (MONDO:0041656), STEMI (MONDO:0041656)

## Full-text entities

- **Diseases:** diabetes (MESH:D003920), ST-segment elevation myocardial infarction (MESH:D000072657), Chest Pain (MESH:D002637), main disease (MESH:D003324), death (MESH:D003643)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12141884/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12141884/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12141884/full.md

---
Source: https://tomesphere.com/paper/PMC12141884